OMC enters the week before its October 13 earnings with short sellers quietly adding to positions and options markets pricing in more downside protection than usual — a combination that sits uneasily against an analyst consensus still implying meaningful upside.
Short interest has climbed back toward the top of its recent range. It rose 7.6% over the past week to 14.1% of the free float — roughly 27.2 million shares — after spending most of August drifting lower. The move reverses a gradual unwind that ran through mid-August and brings shorts back to levels last seen at the start of the month. Notably, the build happened even as the stock fell 8.8% over the past month to $79.85, suggesting bears are not covering into the weakness. Days-to-cover on the FINRA fortnightly print sits at 14 — that is a long time to unwind a position, and it underscores just how substantial the short book has become relative to average daily volume.
The borrow market tells a more relaxed story. Availability is running at around 454% — meaning there are more than four shares available to borrow for every share already lent out — well clear of the tightest reading of the past year at 79%. Cost to borrow has eased to 0.46%, down from roughly 0.56% a month ago, and is now at the lowest level in the 30-day window. Shorts are not paying a squeeze premium. They are borrowing cheaply into a position that is growing. That combination — rising short interest, cheap borrow, ample availability — reads as deliberate and unhurried pressure rather than a crowded or panicked trade.
Options traders have turned more cautious in step. The put/call ratio moved to 1.30 this week, about 1.7 standard deviations above its 20-day average of 1.12. The shift happened abruptly: through September 4 the PCR was tracking around 1.04, then jumped above 1.29 on September 8 and has stayed there. That marks the most defensive options stance in several months, though it remains well below the 52-week high of 2.46. The timing aligns closely with the short-interest rebuild — both moved in the same direction at the same time, which makes the combined signal harder to dismiss as noise.
The Street consensus sits constructively above the current price. The mean analyst target is $102, implying roughly 28% upside from $79.85. The most recent move of note came after Q2 results in late July, when Citigroup trimmed its target from $105 to $100 while holding its Buy rating, and Wells Fargo nudged its Overweight target up from $91 to $93. Goldman Sachs initiated coverage in June with a Buy and a $146 target — a figure that now looks quite distant from where the stock trades. Morgan Stanley sits at Equal-Weight with an $83 target, barely above the current price. On valuation, OMC trades at roughly 7x trailing earnings and 5.8x EV/EBITDA, both of which have compressed over the past 30 days as the stock has sold off. The forward EPS growth factor scores in the 90th percentile of the universe, which is the standout positive in the factor profile. The short-score rank, however, is in the 11th percentile — meaning the stock ranks among the more heavily shorted names across the market.
State Street trimmed its stake from 9.7% to 8.6% in a filing dated August 7, while Vanguard Portfolio Management also reduced its disclosed position from 5.22% to 4.74% — both passive managers trimming rather than any activist shift. None of the activist filings on record carry a 13D designation, so there is no activist pressure to factor in. Insider activity has been minimal: the only open-market transaction in the past 90 days was a director sale of roughly $123,000 worth of stock in late August — small enough to carry little informational weight.
What to watch into October 13: the last earnings print in late July produced a muted one-day move of +0.2%, followed by a -0.7% drift over five days — but the April print saw a -2.0% day-one move and a -4.0% five-day follow-through. The question heading into Q3 results is whether the short rebuild and options defensiveness reflect genuine concern about that April-style outcome, or whether they are pre-earnings hedges that fade on any in-line print.
See the live data behind this article on ORTEX.
Open OMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
